Nasr, L.F.; Zoghbi, M.; Lazcano, R.; Nakazawa, M.; Bishop, A.J.; Farooqi, A.; Mitra, D.; Guadagnolo, B.A.; Benjamin, R.; Patel, S.;
et al. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers 2024, 16, 1763.
https://doi.org/10.3390/cancers16091763
AMA Style
Nasr LF, Zoghbi M, Lazcano R, Nakazawa M, Bishop AJ, Farooqi A, Mitra D, Guadagnolo BA, Benjamin R, Patel S,
et al. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers. 2024; 16(9):1763.
https://doi.org/10.3390/cancers16091763
Chicago/Turabian Style
Nasr, Lewis F., Marianne Zoghbi, Rossana Lazcano, Michael Nakazawa, Andrew J. Bishop, Ahsan Farooqi, Devarati Mitra, Beverly Ashleigh Guadagnolo, Robert Benjamin, Shreyaskumar Patel,
and et al. 2024. "High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience" Cancers 16, no. 9: 1763.
https://doi.org/10.3390/cancers16091763
APA Style
Nasr, L. F., Zoghbi, M., Lazcano, R., Nakazawa, M., Bishop, A. J., Farooqi, A., Mitra, D., Guadagnolo, B. A., Benjamin, R., Patel, S., Ravi, V., Araujo, D. M., Livingston, A., Zarzour, M. A., Conley, A. P., Ratan, R., Somaiah, N., Lazar, A. J., Roland, C.,
... Nassif Haddad, E. F.
(2024). High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers, 16(9), 1763.
https://doi.org/10.3390/cancers16091763
